Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|February 5, 2019
Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of InsulinomasU N Pallavi, Vindhya Malasani, Ishita Sen, et al.
The British Journal of Radiology|July 21, 2018
Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM)Parul Thakral, Ishita Sen, Vineet Pant, et al.
The Indian Journal of Medical Research|June 14, 2014
An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patientsParul Thakral, Suhas Singla, Madhav Prasad Yadav, et al.
Clinical Nuclear Medicine|May 20, 2024
Potential Efficacy of 68 Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal AdenocarcinomaSubha Shankar Das, Sunita Ahlawat, Parul Thakral, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|May 1, 2020
Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate CancerU N Pallavi, Sanjay Gogoi, Parul Thakral, et al.
Current Radiopharmaceuticals|September 6, 2016
Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins LymphomaParul Thakral, Suhas Singla, Atul Vashist, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency StudyGunjan Kayal, Nathaly Barbosa, Carlos Calderón Marín, et al.
The Lancet. Oncology|January 13, 2024
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective studyMike M Sathekge, Ismaheel O Lawal, Chandrasekhar Bal, et al.
Pageof 3